Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1.
J Virol. 1986 Aug;59(2):377-83. doi: 10.1128/JVI.59.2.377-383.1986.
J Virol. 1986.
PMID: 3016304
Free PMC article.
Determination of the mutation rate of a retrovirus.
Leider JM, Palese P, Smith FI.
Leider JM, et al.
J Virol. 1988 Sep;62(9):3084-91. doi: 10.1128/JVI.62.9.3084-3091.1988.
J Virol. 1988.
PMID: 2841464
Free PMC article.
Item in Clipboard
The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity.
Vlasak R, Luytjes W, Leider J, Spaan W, Palese P.
Vlasak R, et al.
J Virol. 1988 Dec;62(12):4686-90. doi: 10.1128/JVI.62.12.4686-4690.1988.
J Virol. 1988.
PMID: 3184275
Free PMC article.
Item in Clipboard
Sex-specific impact of severe obesity in the outcomes of hospitalized patients with COVID-19: a large retrospective study from the Bronx, New York.
Guerson-Gil A, Palaiodimos L, Assa A, Karamanis D, Kokkinidis D, Chamorro-Pareja N, Kishore P, Leider JM, Brandt LJ.
Guerson-Gil A, et al. Among authors: leider jm.
Eur J Clin Microbiol Infect Dis. 2021 Sep;40(9):1963-1974. doi: 10.1007/s10096-021-04260-z. Epub 2021 May 6.
Eur J Clin Microbiol Infect Dis. 2021.
PMID: 33956286
Free PMC article.
Item in Clipboard
Outcomes after an excisional procedure for cervical intraepithelial neoplasia in HIV-infected women.
Reimers LL, Sotardi S, Daniel D, Chiu LG, Van Arsdale A, Wieland DL, Leider JM, Xue X, Strickler HD, Garry DJ, Goldberg GL, Einstein MH.
Reimers LL, et al. Among authors: leider jm.
Gynecol Oncol. 2010 Oct;119(1):92-7. doi: 10.1016/j.ygyno.2010.06.012.
Gynecol Oncol. 2010.
PMID: 20605046
Free PMC article.
Item in Clipboard
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection.
Fätkenheuer G, Nelson M, Lazzarin A, Konourina I, Hoepelman AI, Lampiris H, Hirschel B, Tebas P, Raffi F, Trottier B, Bellos N, Saag M, Cooper DA, Westby M, Tawadrous M, Sullivan JF, Ridgway C, Dunne MW, Felstead S, Mayer H, van der Ryst E; MOTIVATE 1 and MOTIVATE 2 Study Teams.
Fätkenheuer G, et al.
N Engl J Med. 2008 Oct 2;359(14):1442-55. doi: 10.1056/NEJMoa0803154.
N Engl J Med. 2008.
PMID: 18832245
Free article.
Item in Clipboard
Maraviroc for previously treated patients with R5 HIV-1 infection.
Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, Horban A, Nadler J, Clotet B, Karlsson A, Wohlfeiler M, Montana JB, McHale M, Sullivan J, Ridgway C, Felstead S, Dunne MW, van der Ryst E, Mayer H; MOTIVATE Study Teams.
Gulick RM, et al.
N Engl J Med. 2008 Oct 2;359(14):1429-41. doi: 10.1056/NEJMoa0803152.
N Engl J Med. 2008.
PMID: 18832244
Free PMC article.
Clinical Trial.
Item in Clipboard
Understanding adherence to HIV medication.
Leider JM, Kalkut G.
Leider JM, et al.
Ann Intern Med. 2000 Mar 7;132(5):418. doi: 10.7326/0003-4819-132-5-200003070-00018.
Ann Intern Med. 2000.
PMID: 10691599
No abstract available.
Item in Clipboard
Cite
Cite